期刊文献+

药物多晶型的研究进展 被引量:16

Progress in the Research of Pharmaceutical Polymorph
下载PDF
导出
摘要 多晶型研究是制药领域的一个研究热点,而多晶型体系的分子组装规律及其控制手段是最为关键的研究内容。介绍了多晶型的分子组装规律,即成核理论(包括经典成核理论以及新兴的二步成核理论),以及多晶型的调控方法,并重点介绍目前新型的调控手段(如离子液体、模板剂以及微通道技术等)。此外,结合药物晶型转化的实际案例,说明晶型转化技术在药物产品质量调控中的重要作用。 The study on pharmaceutical polymorphs is a hot topic in the field of drug. Meanwhile, the molecular assembly rules and the controlling methods of pharmaceutical polymorphs are the key contents in the research of polymorphs. In this paper, the nucleation theories, including the classical nucleation theory and two-step nucleation theory, as well as the methods about how to control pharmaceutical poly-morph are introduced. In particular, some new strategies for polymorph regulation are highlighted, such as ionic liquid, template agent and microchannel technology. In addition, two practical examples are used to illustrate the important role of phase transformation in improving the quality of pharmaceutical products.
作者 赵绍磊 王灵宇 吴送姑 Zhao Shaolei;Wang Lingyu;Wu Songgu(School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China;National Engineering Research Center of Industrial Crystallization Technology, Tianjin University, Tianjin 300072, China)
出处 《化学工业与工程》 CAS CSCD 2018年第3期12-21,共10页 Chemical Industry and Engineering
基金 国家自然科学基金创新研究群体项目(21621004) 国家科技重大专项(2017ZX09101001)
关键词 药物多晶型 成核理论 晶型控制 晶型转化 pharmaceutical polymorph nucleation theory polymorph regulation phase transformation
  • 相关文献

参考文献1

二级参考文献47

  • 1马廷升,朱兰翠.药物生物利用度影响因素的动态分析[J].怀化学院学报,2006,25(2):76-77. 被引量:6
  • 2张伟国,刘昌孝.多晶型药物的生物利用度研究概况[J].天津药学,2007,19(2):59-61. 被引量:13
  • 3郑丽莉.The effect of pharmaceutical polymorph for the quality of drugs[J]China Pharmacist (中国药师),2008(03):347-349.
  • 4Jiang Shanfeng,Pieter J Jansens,Joop Hter Horst. Control over polymorph formation of o-aminobenzoic acid[J].Crystal Growth and Design,2010.2541-2547.
  • 5Martínez-Ohárriz M C,Martín C,Go(n)i M M,RodríguezEspinosa C Tros De Ilarduya-Apaolaza M C Sánchez M. Polymorphism of diflunisal:isolation and solid-state characteristics of a new crystal form[J].Journal of Pharmaceutical Sciences,1994,(02):174-177.
  • 6Damir Kralj,Ljerka Brecevic,Jasminka Kontrec. Vaterite growth and dissolution in aqueous solution (Ⅲ):Kinetics of transformation[J].Journal of Crystal Growth,1997.248-257.
  • 7Davey R J,Blagden N,Righini S,Alison H Ferrari E S. Nucleation control in solution mediated polymorphic phase transformations:the case of 2,6-dihydroxybenzoic acid[J].The Journal of Physical Chemistry(B)Materials Surfaces Interfaces & Physical,2001,(08):1954-1959.
  • 8Kostas Saranteas,Roger Bakale,Hong Yaping,Hoa Luong,Reza Foroughi,Stephen Wald. Process design and scale-up elements for solvent mediated polymorphic controlled tecastemizole crystallization[J].Organic Process Research & Development,2005.911-922.
  • 9Shoji Maruyama,Hiroshi Oshima,Jyoji Kato. Crystal structure and solvent-mediated transformation of taltireline polymorphs[J].Chemical Engineering Journal,1999.193-200.
  • 10Shoji Maruyama,Hiroshi Oshima. Mechanism of the solvent-mediated transformation of taltirelin polymorphs promoted by methanol[J].Chemical Engineering Journal,2001,(1/2/3):1-7.

共引文献19

同被引文献102

引证文献16

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部